\-\ Texto\\:\\ \ \(0\)\
\-\ visual\\ acuity\\:\\	\\	\\	right\\ 20\\/25\\ and\\ left\\ 20\\/20\ \(0\)\
\-\ heent\\:\\	\\	\\	\\	\ \(0\)\
\-\ pupils\\ round\\ and\\ reactive\\,\\ \ \(0\)\
\-\ no\\ papilledema\ \(2\)\
\-\ slit\\ lamp\\ exam\\ was\\ within\\ normal\\ limits\ \(0\)\
\-\ left\\ extraocular\\ muscles\\ intact\ \(0\)\
\-\ right\\ eye\\ unable\\ to\\ look\\ superiorly\\ or\\ laterally\\,\\ limited\\ ability\\ to\\ look\\ medially\\ \ \(0\)\
\-\ numbness\\ of\\ the\\ cornea\ \(0\)\
\-\ ptosis\\ with\\ minimal\\ redness\ \(0\)\
\-\ high\\ dose\\ steroids\ \(5\)\
\-\ image\\ 1\\ \\â\\€\\“\\ axial\\ nect\\:\\ \\ subtle\\ soft\\ tissue\\ density\\ right\\ parasellar\\ region\ \(0\)\
\-\ image\\ 2\\ \\â\\€\\“\\ axial\\ cect\\:\\ \\ the\\ cavernous\\ sinus\\ is\\ distended\\ on\\ the\\ right\\ with\\ irregular\\ enhancement\\ of\\ parasellar\\ density\ \(0\)\
\-\ image\\ 3\\ \\â\\€\\“\\ axial\\ fat\\ saturation\\ t1wi\\:\\ isointense\\ extra\\-axial\\ lesion\\ right\\ parasellar\\ region\\,\\ appears\\ to\\ encase\\ cavernous\\ carotids\\;\\ left\\ sinus\\ disease\ \(0\)\
\-\ image\\ 4\\ \\â\\€\\“\\ axial\\ t2wi\\:\\ slight\\ hyperintense\\ extra\\-axial\\ lesion\\ right\\ cavernous\\ sinus\\;\\ left\\ sinus\\ disease\ \(0\)\
\-\ image\\ 5\\ \\â\\€\\“\\ mra\\:\\ normal\\ mra\\ without\\ definite\\ carotid\\ involvement\\ \ \(0\)\
\-\ image\\ 6\\ \\â\\€\\“\\ sagittal\\ t1wi\\+\\:\\ diffuse\\ enhancement\\ of\\ lesion\ \(0\)\
\-\ image\\ 7\\ \\â\\€\\“\\ axial\\ flair\\ t1wi\\+\\:\\ diffuse\\ enhancement\\ of\\ lesion\ \(0\)\
\-\ tolosa\\ hunt\ \(0\)\
\-\ inflammation\\,\\ neoplasm\\ \\(meningioma\\,\\ craniopharyngioma\\,\\ pituitary\\ adenoma\\)\\,\\ metastasis\\,\\ infection\\ \\(meningitis\\,\\ sarcoidosis\\,\\ actinomycosis\\)\\,\\ meningeal\\ non\\-hodgkin\\ lymphoma\\,\\ trauma\\,\\ aneurysm\\ or\\ carotid\\ cavernous\\ fistula\ \(0\)\
\-\ patient\\ is\\ a\\ 10\\ year\\ old\\ female\\ initially\\ seen\\ by\\ the\\ pcp\\ for\\ nausea\\,\\ vomiting\\,\\ and\\ headache\\ over\\ the\\ right\\ orbital\\/temporal\\ region\\.\\ her\\ symptoms\\ were\\ initially\\ attributed\\ to\\ sinus\\ disease\\ for\\ which\\ she\\ began\\ a\\ course\\ of\\ amoxicillin\\.\\ her\\ symptoms\\ did\\ not\\ improve\\ and\\ she\\ was\\ switched\\ to\\ cefuroxime\\.\\ \\ she\\ was\\ then\\ seen\\ again\\ by\\ the\\ pcp\\ due\\ to\\ worsening\\ headache\\,\\ right\\ eye\\ pain\\,\\ and\\ worsening\\ intermittent\\ double\\ vision\\ over\\ the\\ last\\ month\\,\\ more\\ noticeably\\ within\\ the\\ last\\ week\\.\\ she\\ was\\ then\\ referred\\ to\\ the\\ ophthalmology\\ clinic\\ for\\ ophthalmoplegia\\ and\\ inability\\ to\\ fully\\ elevate\\ the\\ right\\ eyelid\\.\ \(0\)\
\-\ in\\ this\\ patient\\,\\ the\\ inability\\ to\\ look\\ superiorly\\ is\\ due\\ to\\ involvement\\ of\\ cn\\ iv\\.\\ the\\ trochlear\\ nerve\\ innervates\\ the\\ superior\\ oblique\\ muscle\\.\\ \\ cn\\ vi\\ involvement\\ is\\ demonstrated\\ with\\ the\\ inability\\ to\\ gaze\\ laterally\\.\\ \\ the\\ abducens\\ nerve\\ innervates\\ the\\ lateral\\ rectus\\ muscle\\ allowing\\ for\\ lateral\\ gaze\\.\\ \\ cn\\ iii\\ involvement\\ seen\\ with\\ ptosis\\.\\ the\\ eyelids\\ are\\ elevated\\ by\\ the\\ contraction\\ of\\ the\\ levator\\ palpebrae\\ superioris\\ which\\ is\\ innervated\\ by\\ cniii\\.\\ \\ cn\\ v1\\ involvement\\ resulted\\ in\\ loss\\ of\\ corneal\\ reflex\\ as\\ it\\ provides\\ the\\ sensory\\ fibers\\ to\\ the\\ eye\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.06780840269706168\ \(0\)\
\-\ parasellar\\:\\ 0\\.051911397543409454\ \(0\)\
\-\ image\\:\\ 0\\.047063788826406064\ \(0\)\
\-\ cn\\:\\ 0\\.04630741278378228\ \(0\)\
\-\ t1wi\\+\\:\\ 0\\.04441067216104029\ \(0\)\
\-\ innervates\\:\\ 0\\.04091874681816903\ \(0\)\
\-\ cavernous\\:\\ 0\\.03993438952188293\ \(0\)\
\-\ involvement\\:\\ 0\\.03944507124216394\ \(0\)\
\-\ sinus\\:\\ 0\\.03935968475620199\ \(0\)\
\-\ inability\\:\\ 0\\.037054121550667646\ \(0\)\
\-\ look\\:\\ 0\\.03593255979914418\ \(0\)\
\-\ axial\\:\\ 0\\.03071525788498579\ \(0\)\
\-\ ptosis\\:\\ 0\\.029849605370631405\ \(0\)\
\-\ gaze\\:\\ 0\\.029318821916435804\ \(0\)\
\-\ pcp\\:\\ 0\\.02727617653553825\ \(0\)\
\-\ eye\\:\\ 0\\.027086220204875906\ \(0\)\
\-\ \\:\\:\\ 0\\.025623358548906763\ \(0\)\
\-\ she\\:\\ 0\\.024169129888707026\ \(0\)\
\-\ laterally\\:\\ 0\\.024131822333659188\ \(0\)\
\-\ mra\\:\\ 0\\.024131822333659188\ \(0\)\
\-\ superiorly\\:\\ 0\\.023955039866096116\ \(0\)\
\-\ extra\\-axial\\:\\ 0\\.022936214342192358\ \(0\)\
\-\ orbital\\/temporal\\:\\ 0\\.022205336080520145\ \(0\)\
\-\ superioris\\:\\ 0\\.022205336080520145\ \(0\)\
\-\ cniii\\:\\ 0\\.022205336080520145\ \(0\)\
\-\ slit\\:\\ 0\\.020459373409084516\ \(0\)\
\-\ lamp\\:\\ 0\\.020459373409084516\ \(0\)\
\-\ tolosa\\:\\ 0\\.020459373409084516\ \(0\)\
\-\ palpebrae\\:\\ 0\\.020459373409084516\ \(0\)\
\-\ right\\:\\ 0\\.02044001355665932\ \(0\)\
\-\ cefuroxime\\:\\ 0\\.01943805071863574\ \(0\)\
\-\ noticeably\\:\\ 0\\.01943805071863574\ \(0\)\
\-\ trochlear\\:\\ 0\\.01943805071863574\ \(0\)\
\-\ carotid\\:\\ 0\\.019304341573088978\ \(0\)\
\-\ ophthalmoplegia\\:\\ 0\\.018713410737648886\ \(0\)\
\-\ elevate\\:\\ 0\\.018713410737648886\ \(0\)\
\-\ v1\\:\\ 0\\.018713410737648886\ \(0\)\
\-\ last\\:\\ 0\\.01839159924454904\ \(0\)\
\-\ region\\:\\ 0\\.018238800205838634\ \(0\)\
\-\ 20\\/25\\:\\ 0\\.01815133630108916\ \(0\)\
\-\ innervated\\:\\ 0\\.01815133630108916\ \(0\)\
\-\ cornea\\:\\ 0\\.017692088047200107\ \(0\)\
\-\ nect\\:\\ 0\\.017692088047200107\ \(0\)\
\-\ encase\\:\\ 0\\.017692088047200107\ \(0\)\
\-\ hunt\\:\\ 0\\.017692088047200107\ \(0\)\
\-\ lesion\\:\\ 0\\.017537080362724982\ \(0\)\
\-\ initially\\:\\ 0\\.017521311558010982\ \(0\)\
\-\ enhancement\\:\\ 0\\.01730847934098012\ \(0\)\
\-\ amoxicillin\\:\\ 0\\.017303799181136486\ \(0\)\
\-\ levator\\:\\ 0\\.017303799181136486\ \(0\)\
\-\ actinomycosis\\:\\ 0\\.016967448066213253\ \(0\)\
\-\ abducens\\:\\ 0\\.016967448066213253\ \(0\)\
\-\ eyelids\\:\\ 0\\.016967448066213253\ \(0\)\
\-\ worsening\\:\\ 0\\.016949521261464977\ \(0\)\
\-\ switched\\:\\ 0\\.01640537362965353\ \(0\)\
\-\ 20\\/20\\:\\ 0\\.016165297609995282\ \(0\)\
\-\ corneal\\:\\ 0\\.016165297609995282\ \(0\)\
\-\ carotids\\:\\ 0\\.015744506464748013\ \(0\)\
\-\ vi\\:\\ 0\\.015744506464748013\ \(0\)\
\-\ contraction\\:\\ 0\\.015744506464748013\ \(0\)\
\-\ cect\\:\\ 0\\.015557836509700855\ \(0\)\
\-\ nerve\\:\\ 0\\.015511063609507839\ \(0\)\
\-\ muscle\\:\\ 0\\.015462545256555894\ \(0\)\
\-\ eyelid\\:\\ 0\\.015384050939204755\ \(0\)\
\-\ then\\:\\ 0\\.015319732384997934\ \(0\)\
\-\ headache\\:\\ 0\\.014785820844160191\ \(0\)\
\-\ ophthalmology\\:\\ 0\\.014536513819252077\ \(0\)\
\-\ by\\:\\ 0\\.014336230763172541\ \(0\)\
\-\ redness\\:\\ 0\\.014307365763318258\ \(0\)\
\-\ non\\-hodgkin\\:\\ 0\\.014307365763318258\ \(0\)\
\-\ density\\:\\ 0\\.014164389707103068\ \(0\)\
\-\ allowing\\:\\ 0\\.013903479994866925\ \(0\)\
\-\ meningeal\\:\\ 0\\.013723482604483687\ \(0\)\
\-\ attributed\\:\\ 0\\.013638088267769124\ \(0\)\
\-\ acuity\\:\\ 0\\.013555494255620533\ \(0\)\
\-\ papilledema\\:\\ 0\\.013398012248110875\ \(0\)\
\-\ provides\\:\\ 0\\.0133228158673812\ \(0\)\
\-\ t1wi\\:\\ 0\\.013249799401705502\ \(0\)\
\-\ extraocular\\:\\ 0\\.013178840013880071\ \(0\)\
\-\ ability\\:\\ 0\\.013109824965547289\ \(0\)\
\-\ fully\\:\\ 0\\.013042650539647638\ \(0\)\
\-\ diffuse\\:\\ 0\\.013032782974182946\ \(0\)\
\-\ \\,\\:\\ 0\\.012955897342137179\ \(0\)\
\-\ her\\:\\ 0\\.012944139337455595\ \(0\)\
\-\ t2wi\\:\\ 0\\.01291344828678227\ \(0\)\
\-\ to\\:\\ 0\\.012908859701047444\ \(0\)\
\-\ seen\\:\\ 0\\.01276041018942839\ \(0\)\
\-\ saturation\\:\\ 0\\.012673372267124021\ \(0\)\
\-\ rectus\\:\\ 0\\.012454200032893218\ \(0\)\
\-\ medially\\:\\ 0\\.012252581121876752\ \(0\)\
\-\ resulted\\:\\ 0\\.012157517323431294\ \(0\)\
\-\ fibers\\:\\ 0\\.0121112978305643\ \(0\)\
\-\ pupils\\:\\ 0\\.011769228457367671\ \(0\)\
\-\ reflex\\:\\ 0\\.011729560051906363\ \(0\)\
\-\ definite\\:\\ 0\\.011652049576675245\ \(0\)\
\-\ due\\:\\ 0\\.011487542332256118\ \(0\)\
\-\ improve\\:\\ 0\\.011468107171096179\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.011398133457980119\ \(0\)\
\-\ dose\\:\\ 0\\.011263760710611623\ \(0\)\
\-\ meningitis\\:\\ 0\\.01116748561534664\ \(0\)\
\-\ sensory\\:\\ 0\\.011136194632982517\ \(0\)\
\-\ over\\:\\ 0\\.010960416071234068\ \(0\)\
\-\ began\\:\\ 0\\.010898947239885035\ \(0\)\
\-\ pituitary\\:\\ 0\\.010788208893736126\ \(0\)\
\-\ symptoms\\:\\ 0\\.010728753032232438\ \(0\)\
\-\ isointense\\:\\ 0\\.010580347373111433\ \(0\)\
\-\ fistula\\:\\ 0\\.010555530505496792\ \(0\)\
\-\ disease\\:\\ 0\\.010554691747221946\ \(0\)\
\-\ heent\\:\\ 0\\.010411554651995664\ \(0\)\
\-\ distended\\:\\ 0\\.010411554651995664\ \(0\)\
\-\ double\\:\\ 0\\.010411554651995664\ \(0\)\
\-\ numbness\\:\\ 0\\.010342539603662883\ \(0\)\
\-\ again\\:\\ 0\\.010342539603662883\ \(0\)\
\-\ \\;\\:\\ 0\\.010203633191196946\ \(0\)\
\-\ reactive\\:\\ 0\\.010188498235518472\ \(0\)\
\-\ steroids\\:\\ 0\\.01012525913947042\ \(0\)\
\-\ slight\\:\\ 0\\.01012525913947042\ \(0\)\
\-\ iii\\:\\ 0\\.01010452740361018\ \(0\)\
\-\ oblique\\:\\ 0\\.010003353494982133\ \(0\)\
\-\ was\\:\\ 0\\.00995745614321095\ \(0\)\
\-\ unable\\:\\ 0\\.009944544013881399\ \(0\)\
\-\ vision\\:\\ 0\\.009944544013881399\ \(0\)\
\-\ subtle\\:\\ 0\\.009887076311699609\ \(0\)\
\-\ flair\\:\\ 0\\.009868208120946062\ \(0\)\
\-\ muscles\\:\\ 0\\.00983089052450994\ \(0\)\
\-\ visual\\:\\ 0\\.009757874058834241\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.009722144499660548\ \(0\)\
\-\ left\\:\\ 0\\.009633302461188058\ \(0\)\
\-\ clinic\\:\\ 0\\.009617899622676028\ \(0\)\
\-\ lateral\\:\\ 0\\.009303113579972546\ \(0\)\
\-\ round\\:\\ 0\\.009298625804945186\ \(0\)\
\-\ intermittent\\:\\ 0\\.009239355030612205\ \(0\)\
\-\ inflammation\\:\\ 0\\.009152984568449403\ \(0\)\
\-\ limited\\:\\ 0\\.009083204713161404\ \(0\)\
\-\ adenoma\\:\\ 0\\.008988650760216654\ \(0\)\
\-\ hyperintense\\:\\ 0\\.008936171951897153\ \(0\)\
\-\ limits\\:\\ 0\\.00887207455728465\ \(0\)\
\-\ nausea\\:\\ 0\\.008665591980560033\ \(0\)\
\-\ irregular\\:\\ 0\\.008585256051653348\ \(0\)\
\-\ sagittal\\:\\ 0\\.008585256051653348\ \(0\)\
\-\ aneurysm\\:\\ 0\\.008507403312451645\ \(0\)\
\-\ minimal\\:\\ 0\\.008474760630732488\ \(0\)\
\-\ meningioma\\:\\ 0\\.00827730311449641\ \(0\)\
\-\ 7\\:\\ 0\\.008247493397501441\ \(0\)\
\-\ vomiting\\:\\ 0\\.008218032340163427\ \(0\)\
\-\ within\\:\\ 0\\.008212248908746002\ \(0\)\
\-\ course\\:\\ 0\\.00812224544951043\ \(0\)\
\-\ referred\\:\\ 0\\.00812224544951043\ \(0\)\
\-\ metastasis\\:\\ 0\\.008057298051133316\ \(0\)\
\-\ which\\:\\ 0\\.008035992882833999\ \(0\)\
\-\ appears\\:\\ 0\\.008011911387398611\ \(0\)\
\-\ intact\\:\\ 0\\.007906208115108858\ \(0\)\
\-\ iv\\:\\ 0\\.007854974653554392\ \(0\)\
\-\ did\\:\\ 0\\.007771835367740362\ \(0\)\
\-\ for\\:\\ 0\\.007346177820077734\ \(0\)\
\-\ neoplasm\\:\\ 0\\.007330369208846167\ \(0\)\
\-\ the\\:\\ 0\\.007312934455355521\ \(0\)\
\-\ week\\:\\ 0\\.007309862514680675\ \(0\)\
\-\ elevated\\:\\ 0\\.007303063882516531\ \(0\)\
\-\ 10\\:\\ 0\\.0072559804240476325\ \(0\)\
\-\ is\\:\\ 0\\.00708174783859856\ \(0\)\
\-\ superior\\:\\ 0\\.0068734098162574085\ \(0\)\
\-\ normal\\:\\ 0\\.006748677353144086\ \(0\)\
\-\ fat\\:\\ 0\\.006546378647057011\ \(0\)\
\-\ month\\:\\ 0\\.006457467357180376\ \(0\)\
\-\ 6\\:\\ 0\\.006428514260390111\ \(0\)\
\-\ demonstrated\\:\\ 0\\.006315919351276996\ \(0\)\
\-\ 5\\:\\ 0\\.0062976333059046935\ \(0\)\
\-\ infection\\:\\ 0\\.006256968700435282\ \(0\)\
\-\ loss\\:\\ 0\\.0062480205855628195\ \(0\)\
\-\ lymphoma\\:\\ 0\\.006151633839772004\ \(0\)\
\-\ 4\\:\\ 0\\.0059974103405013735\ \(0\)\
\-\ high\\:\\ 0\\.005890544234450417\ \(0\)\
\-\ trauma\\:\\ 0\\.005886671994352466\ \(0\)\
\-\ more\\:\\ 0\\.005383315640584802\ \(0\)\
\-\ soft\\:\\ 0\\.005241629128447229\ \(0\)\
\-\ 1\\:\\ 0\\.00512172888654838\ \(0\)\
\-\ tissue\\:\\ 0\\.005101816595598473\ \(0\)\
\-\ without\\:\\ 0\\.005068043240196877\ \(0\)\
\-\ or\\:\\ 0\\.005045454654729005\ \(0\)\
\-\ 3\\:\\ 0\\.005040240621427052\ \(0\)\
\-\ were\\:\\ 0\\.0048873711251635294\ \(0\)\
\-\ it\\:\\ 0\\.004838409029050419\ \(0\)\
\-\ exam\\:\\ 0\\.0047285489671273\ \(0\)\
\-\ 2\\:\\ 0\\.004635023920681477\ \(0\)\
\-\ female\\:\\ 0\\.00442508884495676\ \(0\)\
\-\ patient\\:\\ 0\\.004315324588999436\ \(0\)\
\-\ \\(\\:\\ 0\\.0036391018954350656\ \(0\)\
\-\ \\)\\:\\ 0\\.003594648322988942\ \(0\)\
\-\ as\\:\\ 0\\.0032558627352496923\ \(0\)\
\-\ not\\:\\ 0\\.0031103744880149505\ \(0\)\
\-\ are\\:\\ 0\\.002934191114684135\ \(0\)\
\-\ and\\:\\ 0\\.002720539129454183\ \(0\)\
\-\ pain\\:\\ 0\\.002628735938364571\ \(0\)\
\-\ this\\:\\ 0\\.0024210005373151967\ \(0\)\
\-\ year\\:\\ 0\\.0024083256152970145\ \(0\)\
\-\ of\\:\\ 0\\.0023476836432844016\ \(0\)\
\-\ old\\:\\ 0\\.002203865483280238\ \(0\)\
\-\ no\\:\\ 0\\.0021673656189012645\ \(0\)\
\-\ in\\:\\ 0\\.0021229079604043067\ \(0\)\
\-\ a\\:\\ 0\\.001997983888254918\ \(0\)\
\-\ on\\:\\ 0\\.001823403053817199\ \(0\)\
\-\ with\\:\\ 0\\.0011788833862961183\ \(0\)\
\-\ \\.\\:\\ 0\\.0010730338366956053\ \(0\)\
